Albireo Pharma Inc.
13F holders, Q1 2024 (March 31)3holders
$0.00avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Albireo Pharma Inc. in their 13F filings. The largest holders were MAI Capital Management ($0), Tucker Asset Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Albireo Pharma Inc.
- CUSIP
- 013CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| MAI Capital Management | 0.00% | Reduce -0.5% | 150,660 | $0 |
| Tucker Asset Management LLC | 0.00% | No change | 150 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ALBIREO PHARMA INC's weight in each manager's 13F, not the share of Albireo Pharma Inc. the manager owns.